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Hashimoto?s thyroiditis (HT) is an autoimmune disorder that drives the function of thyroid gland to the
sequential clinical states: euthyroidism (normal condition), subclinical hypothyroidism (asymptomatic pe-
riod) and overt hypothyroidism (symptomatic period). In this disease, serum thyroid-stimulating hormone
(TSH) levels increase monotonically, stimulating the thyroid follicular cells chronically and initiating benign
(non-cancerous) thyroid nodules at various sites of the thyroid gland. This process can also encourage growth
of papillary thyroid microcarcinoma. Due to prolonged TSH stimulation, thyroid nodules may grow and be-
come clinically relevant without the administration of treatment by thyroid hormone replacement. Papillary
thyroid cancer (80whose incidence is increasing worldwide, is associated with Hashimoto?s thyroiditis. A
stochastic model is developed here to produce the statistical distribution of thyroid nodule sizes and growth
by taking serum TSH value as the continuous input to the model using TSH values from the output of the
patient-specific deterministic model developed for the clinical progression of Hashimoto?s thyroiditis.
